Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study)
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Chronic obstructive pulmonary disease (COPD) is a long-term lung disease that is caused by
cigarette smoking or by breathing in other lung irritants, including pollution, dust, or
chemicals. The purpose of this study is to evaluate the effectiveness of zileuton, a
medication that is used to control asthma symptoms, at reducing the length of a hospital stay
for adults who are hospitalized for a COPD exacerbation, or worsening of COPD symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute